Related Experiment Video
Updated: Oct 17, 2025

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Association between platelet count and multiorgan dysfunction and outcomes in patients with sepsis in the pediatric
Tarek R Hazwani1, Wesam Bin Obaid2, Fatimah Alowirdi2
1Department of Pediatrics, Ministry of National Guard - Health Affairs, Riyadh, Saudi Arabia; College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Insights
Pediatric sepsis outcomes are linked to platelet counts. Thrombocytopenia in children with sepsis may indicate a better prognosis, with lower mortality rates compared to those without low platelets.
Area of Science:
- Pediatric critical care medicine
- Hematology
- Infectious diseases
Background:
- Sepsis poses a significant global threat to children, causing substantial morbidity and mortality.
- Understanding prognostic indicators in pediatric sepsis is crucial for improving patient outcomes.
Purpose of the Study:
- To investigate the correlation between platelet count and outcomes in pediatric severe sepsis and septic shock.
- To determine if thrombocytopenia serves as a predictive marker for sepsis severity and survival in children.
Main Methods:
- Retrospective cohort study of pediatric patients (newborns to 14 years) with sepsis or septic shock admitted to the PICU.
- Patients were categorized into thrombocytopenia (platelet count <150,000/μL) and non-thrombocytopenia groups.
- Data collected included mortality, bacterial blood culture results, and incidence/progression of multiorgan dysfunction syndrome (MODS).
Main Results:
- Thrombocytopenia was observed in 39.8% of the enrolled pediatric sepsis patients.
- A higher mortality rate (29%) was associated with the non-thrombocytopenia group compared to the thrombocytopenia group (12.2%).
- Thrombocytopenia was more prevalent in cases with negative bacterial blood cultures, suggesting an association with non-bacterial sepsis.
Conclusions:
- Low platelet count (thrombocytopenia) in pediatric sepsis patients may be linked to a better clinical outcome.
- Thrombocytopenia appears to be associated with non-bacterial forms of sepsis/septic shock.
- Platelet count can be a valuable indicator for predicting outcomes in pediatric severe sepsis and septic shock.
Background:
Sepsis is one of the leading causes of morbidity and mortality in the pediatric population worldwide. This study aimed to establish a correlation between platelet count and outcomes of severe sepsis/septic shock in pediatric patients.
Methods:
This retrospective cohort study was conducted in the pediatric intensive care unit (PICU) in a pediatric tertiary care medical hospital. Pediatric patients from newborns to 14-year-olds with a diagnosis of sepsis or septic shock who were admitted to the PICU between April 2015 and February 2018 were enrolled. Patients were classified into two groups based on the presence of thrombocytopenia: thrombocytopenia group (TG) with a platelet count <150,000/μL during the first seven days after admission, and non-thrombocytopenia group (NTG) with a platelet count >150,000/μL.
Results:
Overall, 206 children were enrolled, including 82 (39.8%) in the TG and 124 (60.2%) in the NTG. Thrombocytopenia was more common in patients with a negative bacterial blood culture (93.9%, P = 0.007). NTG was associated with a higher mortality rate (29%) than the TG (12.2%, P = 0.005). Multiorgan dysfunction syndrome (MODS) at the onset of sepsis (time zero) was found to be more prevalent in NTG than in TG (P = 0.001), while the progression of MODS over the three days remained the same in both groups.
Conclusion:
Thrombocytopenia was more associated with non-bacterial sepsis/septic shock, and it may indicate a better outcome of sepsis in pediatric patients.
Related Concept Videos
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacokinetics in Pediatric Patients: Drug Distribution
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

